INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 47m ago
House PTR6m ago
SEC 13F6m ago
Robinhood Chain6m ago

Results

20,720 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
AD
Akins Marshall DVP and Chief Comm Officer
CRSCARPENTER TECHNOLOGY CORP
Open-market sale
SELL$104K
235 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

Page 286 of 518
← PrevNext →
29
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL
$302K
2,480 sh
May 4, 2026
May 6, 2026
traded May 4, 2026
+2d
SEC Form 4

Evidence

28
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Open-market sale
SELL$100K
6,600 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

28
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$71K
400 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

28
MM
Mckinney Suzet MDirector
WTFCWINTRUST FINANCIAL CORP
Open-market sale
SELL$74K
500 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

27
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$822K
4,759 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

27
April McClain DelaneyDDependent child
CLHCLEAN HARBORS INC
Partial sale
SELL$1,001 – $15KApr 30, 2026May 6, 2026
traded Apr 30, 2026
+6dHouse PTR

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$75K
620 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$91K
740 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

25
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.46M
1.00M sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

25
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.67M
1.00M sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

24
DL
Duffe LuanaEVP, New Energy
FTITechnipFMC plc
Open-market sale
SELL$139K
1,870 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

23
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$915K
9,910 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

23
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$900K
20.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

23
DJ
Doyle Jonathan JDirector, Hd of Financial Services Group
PIPRPIPER SANDLER COMPANIES
Open-market sale
SELL$483K
6,100 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

22
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$989K
22.5K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

22
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$254K
8,989 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

22
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
9,180 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

21
DJ
Doyle Jonathan JDirector, Hd of Financial Services Group
PIPRPIPER SANDLER COMPANIES
Open-market sale
SELL$23K
300 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

21
HW
Haskins James W.Director
CARECarter Bankshares, Inc.
Open-market sale
SELL$26K
1,000 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

21
April McClain DelaneyDDependent child
PAYXPAYCHEX INC
Partial sale
SELL$1,001 – $15KApr 16, 2026May 6, 2026
traded Apr 16, 2026
+20dHouse PTR

Evidence

21
April McClain DelaneyDDependent child
PAYXPAYCHEX INC
Partial sale
SELL$1,001 – $15KApr 21, 2026May 6, 2026
traded Apr 21, 2026
+15dHouse PTR

Evidence

20
April McClain DelaneyDDependent child
SCISERVICE CORP INTERNATIONAL
Partial sale
SELL$1,001 – $15KApr 30, 2026May 6, 2026
traded Apr 30, 2026
+6dHouse PTR

Evidence

20
MC
Maxwell Michael CaseyPresident - Western Hemisphere
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$568K
13.6K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

20
MC
Maxwell Michael CaseyPresident - Western Hemisphere
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$285K
6,782 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

20
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Open-market sale
SELL$56K
2,688 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
3,908 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$155K
5,460 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$279K
9,935 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
4,803 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
9,030 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$463K
15.9K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$271K
9,645 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

18
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$172K
7,372 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

17
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$618
264 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

17
DJ
Doyle Jonathan JDirector, Hd of Financial Services Group
PIPRPIPER SANDLER COMPANIES
Open-market sale
SELL$24K
300 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$8,750
296 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
2,068 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
April McClain DelaneyDDependent child
VIKViking Holdings Ltd
Partial sale
SELL$1,001 – $15KApr 16, 2026May 6, 2026
traded Apr 16, 2026
+20dHouse PTR

Evidence

16
April McClain DelaneyDDependent child
MORNMorningstar, Inc.
Partial sale
SELL$1,001 – $15KApr 30, 2026May 6, 2026
traded Apr 30, 2026
+6dHouse PTR

Evidence